Greenwich Wealth Management’s Organon & Co OGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-11,604
Closed -$83K 313
2025
Q4
$83K Sell
11,604
-942
-8% -$7.44K ﹤0.01% 282
2025
Q3
$134K Buy
12,546
+2,395
+24% +$23.5K 0.01% 266
2025
Q2
$98K Buy
+10,151
New +$105K ﹤0.01% 244

Other funds holding OGN

Greenwich Wealth Management's OGN Position: Q1 2026 in Review

Greenwich Wealth Management sold out of Organon & Co (OGN) in Q1 2026, closing a stake of 11,604 shares — an estimated $83K sold.

Greenwich Wealth Management first reported a position in OGN in Q2 2025 and held it in 3 quarters. The position peaked at $134K in Q3 2025. 608 funds tracked by Wall St. Rank hold OGN as of Q1 2026.

  • Greenwich Wealth Management reported no remaining Organon & Co position as of Q1 2026 after selling out during the quarter.
  • Greenwich Wealth Management sold 11,604 Organon & Co shares in Q1 2026, an estimated $83K.
  • Greenwich Wealth Management first reported a position in Organon & Co in Q2 2025 and held it in 3 quarters.
  • Greenwich Wealth Management's Organon & Co position peaked at $134K in Q3 2025.
  • 608 funds tracked by Wall St. Rank held Organon & Co as of Q1 2026.

Based on Greenwich Wealth Management's 13F filing for Q1 2026, filed 12 May 2026.